Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

As part of the agreement, which was signed in May 2025, 3SBio will receive $1.25bn, along with a $100m equity investment from ...

Pfizer agreed to an upfront payment of US$1.25 billion, US$150 million for mainland rights and a US$100 million equity ...

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. today announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutical ...

Pfizer Inc. has completed the previously announced global, ex-China, licensing agreement with 3SBio Inc., which grants Pfizer exclusive rights for the development, manufacturing and commercialization ...

On May 19, Pfizer Inc. (NYSE:PFE) announced it had entered into a licensing agreement valued at approximately $6 billion with Chinese biopharmaceutical firm 3SBio Inc.

Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. The agreement with the Medicines Patent Pool, a United Nations-backed public ...

NEW YORK (CBS.MW) - ImmuCell Corporation shares more than doubled in value Wednesday after the biotechnology company signed an agreement with Pfizer's animal health division to license Mast Out ...

In-licensing agreements are legal contracts in which the licensor grants the licensee the right to develop, ... (HKEX:2142) HBM7022. Another example of this strategy is Pfizer (NYSE:PFE) ...

on feb 5, got written notice of pfizer's termination of license agreement between co, pfizer, dated oct 7, 2011 Skip to main content Exclusive news, data and analytics for financial market ...